145 related articles for article (PubMed ID: 16858150)
1. Microarray analysis of sarcomas.
Nielsen TO
Adv Anat Pathol; 2006 Jul; 13(4):166-73. PubMed ID: 16858150
[TBL] [Abstract][Full Text] [Related]
2. Role of gene expression arrays in sarcomas.
Skubitz KM; Skubitz AP
Curr Oncol Rep; 2004 Jul; 6(4):309-14. PubMed ID: 15161587
[TBL] [Abstract][Full Text] [Related]
3. Classification of sarcomas using bioinformatics and molecular profiling.
Dang TA; Man TK
Curr Pharm Biotechnol; 2007 Apr; 8(2):83-91. PubMed ID: 17430156
[TBL] [Abstract][Full Text] [Related]
4. Machine learning analysis of gene expression data reveals novel diagnostic and prognostic biomarkers and identifies therapeutic targets for soft tissue sarcomas.
van IJzendoorn DGP; Szuhai K; Briaire-de Bruijn IH; Kostine M; Kuijjer ML; Bovée JVMG
PLoS Comput Biol; 2019 Feb; 15(2):e1006826. PubMed ID: 30785874
[TBL] [Abstract][Full Text] [Related]
5. cDNA microarray-based translational research in soft tissue sarcoma.
Lubieniecka JM; Nielsen TO
J Surg Oncol; 2005 Dec; 92(4):267-71. PubMed ID: 16299802
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential.
Francis P; Namløs HM; Müller C; Edén P; Fernebro J; Berner JM; Bjerkehagen B; Akerman M; Bendahl PO; Isinger A; Rydholm A; Myklebost O; Nilbert M
BMC Genomics; 2007 Mar; 8():73. PubMed ID: 17359542
[TBL] [Abstract][Full Text] [Related]
7. cDNA microarray analysis of global gene expression in sarcomas.
Schofield D; Triche TJ
Curr Opin Oncol; 2002 Jul; 14(4):406-11. PubMed ID: 12130925
[TBL] [Abstract][Full Text] [Related]
8. Fluorescence in Situ Hybridization (FISH) for Differential Diagnosis of Soft Tissue Sarcomas.
Asif A; Mushtaq S; Hassan U; Akhtar N; Hussain M; Azam M; Qazi R
Asian Pac J Cancer Prev; 2018 Mar; 19(3):655-660. PubMed ID: 29580035
[TBL] [Abstract][Full Text] [Related]
9. Gene expression profiling in sarcomas.
Tschoep K; Kohlmann A; Schlemmer M; Haferlach T; Issels RD
Crit Rev Oncol Hematol; 2007 Aug; 63(2):111-24. PubMed ID: 17555981
[TBL] [Abstract][Full Text] [Related]
10. Experiences from tissue microarray in soft tissue sarcomas.
Nilbert M; Engellau J
Acta Orthop Scand Suppl; 2004 Apr; 75(311):29-34. PubMed ID: 15188663
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA expression signature of human sarcomas.
Subramanian S; Lui WO; Lee CH; Espinosa I; Nielsen TO; Heinrich MC; Corless CL; Fire AZ; van de Rijn M
Oncogene; 2008 Mar; 27(14):2015-26. PubMed ID: 17922033
[TBL] [Abstract][Full Text] [Related]
12. Review with novel markers facilitates precise categorization of 41 cases of diagnostically challenging, "undifferentiated small round cell tumors". A clinicopathologic, immunophenotypic and molecular analysis.
Machado I; Yoshida A; Morales MGN; Abrahão-Machado LF; Navarro S; Cruz J; Lavernia J; Parafioriti A; Picci P; Llombart-Bosch A
Ann Diagn Pathol; 2018 Jun; 34():1-12. PubMed ID: 29661713
[TBL] [Abstract][Full Text] [Related]
13. [Molecular biology of sarcoma and therapeutic choices].
Dufresne A; Cassier P; Heudel P; Pissaloux D; Wang Q; Blay JY; Ray-Coquard I
Bull Cancer; 2015 Jan; 102(1):6-16. PubMed ID: 25609490
[TBL] [Abstract][Full Text] [Related]
14. Expression profiling of synovial sarcoma by cDNA microarrays: association of ERBB2, IGFBP2, and ELF3 with epithelial differentiation.
Allander SV; Illei PB; Chen Y; Antonescu CR; Bittner M; Ladanyi M; Meltzer PS
Am J Pathol; 2002 Nov; 161(5):1587-95. PubMed ID: 12414507
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic and prognostic sarcoma signatures.
Davicioni E; Wai DH; Anderson MJ
Mol Diagn Ther; 2008; 12(6):359-74. PubMed ID: 19035623
[TBL] [Abstract][Full Text] [Related]
16. Molecular profiling of sarcomas: new vistas for precision medicine.
Al-Zaid T; Wang WL; Somaiah N; Lazar AJ
Virchows Arch; 2017 Aug; 471(2):243-255. PubMed ID: 28664413
[TBL] [Abstract][Full Text] [Related]
17. Clinical genomic profiling to identify actionable alterations for investigational therapies in patients with diverse sarcomas.
Groisberg R; Hong DS; Holla V; Janku F; Piha-Paul S; Ravi V; Benjamin R; Kumar Patel S; Somaiah N; Conley A; Ali SM; Schrock AB; Ross JS; Stephens PJ; Miller VA; Sen S; Herzog C; Meric-Bernstam F; Subbiah V
Oncotarget; 2017 Jun; 8(24):39254-39267. PubMed ID: 28424409
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA profiling of primary high-grade soft tissue sarcomas.
Renner M; Czwan E; Hartmann W; Penzel R; Brors B; Eils R; Wardelmann E; Büttner R; Lichter P; Schirmacher P; Mechtersheimer G
Genes Chromosomes Cancer; 2012 Nov; 51(11):982-96. PubMed ID: 22811003
[TBL] [Abstract][Full Text] [Related]
19. Tissue microarray validation of epidermal growth factor receptor and SALL2 in synovial sarcoma with comparison to tumors of similar histology.
Nielsen TO; Hsu FD; O'Connell JX; Gilks CB; Sorensen PH; Linn S; West RB; Liu CL; Botstein D; Brown PO; van de Rijn M
Am J Pathol; 2003 Oct; 163(4):1449-56. PubMed ID: 14507652
[TBL] [Abstract][Full Text] [Related]
20. Lessons from genetic profiling in soft tissue sarcomas.
Nilbert M; Meza-Zepeda LA; Francis P; Berner JM; Namløs HM; Fernebro J; Myklebost O
Acta Orthop Scand Suppl; 2004 Apr; 75(311):35-50. PubMed ID: 15188664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
